MedCity News

What Is the Economic Impact of Medicaid Work Requirements?

Eliminating Blind Spots in the Patient Journey

The webinar, scheduled for May 22, will include executives from PurpleLab and feature Genentech Principal Informatics Systems Lead Dr. Ben Freiberg. Register today!

By Stephanie Baum

BioPharma, Pharma

J&J Gene Therapy for Rare, Progressive Vision-Loss Disorder Fails Phase 3 Test

Johnson & Johnson’s gene therapy for X-linked retinal pigmentosa did not meet the main vision goal of a pivotal study. J&J secured full rights to the program from gene therapy biotech MeiraGtx in 2023.

By Frank Vinluan

Latest News

MedCity Influencers

The Dementia Diagnosis Gap Is Wider Than We Think

Alzheimer’s costs American families upwards of $360 billion per year, and with our growing aging population, the disease needs to be more of a public health priority.

By Elli Kaplan

MedCity Influencers

Acuity-driven Care — Leveraging Multi-level Monitoring for Complex Needs

It's time that the healthcare industry transitioned from isolated point solutions to an integrated care model that incorporates remote monitoring and virtual care management.

By Jeff Bennett

Navigating The Right Steps For Your Healthcare Startup

This webinar will explore how a banking platform approach could be the resource for your company.

By Mercury and MedCity News

What Do Early Stage Life Science Companies Need to Grow?

Scheduled for May 8 at 1 pm ET, the conversation will include Morgan Cheatham, head of healthcare and life sciences at Breyer Capital, Gurdane Bhutani, founder and managing partner of MBX Capital, and will be moderated by Mercury Head of Healthcare and Life Sciences Ben Kromnick.

By Stephanie Baum

MedCity Influencers

Are Therapy-Bots Really Our Best Chance At Solving Population Mental Health?

Like bandaids, AI chatbots can comfort us in times of desperation. But healing a wound takes more than a comforting bandaid.

By Helena Plater-Zyberk

Consumer / Employer, Policy

The Policy Trends the Business Group on Health Is Watching

The Business Group on Health is paying attention to Medicaid cuts, tariffs, threats to ERISA and more.

By Marissa Plescia

Hospitals’ Costs Are Soaring: 3 Stats to Know

Hospitals' costs are climbing steadily — driven by chronic underpayments from payers, growing administrative requirements and increasing labor costs, according to a new report from the American Hospital Association.

By Katie Adams

MedCity Influencers

So What’s the Deal with ICHRA?

The number of US employees offered ICHRAs continues to grow. Yet, headwinds – including competition, individual coverage market uncertainty, and complexity – may hamper the ICHRA opportunity.

By John Syme

BioPharma, Startups

Investor Caution Leads to Dip in Biotech Financings, GlobalData Report Shows

The $6.5 billion raised by biopharmaceutical companies in the first quarter of 2025 is down nearly 20% year over year, according to a report from GlobalData. The firm says investors continue to favor later-stage companies with clinical data.

By Frank Vinluan

Startups, Health Tech Artificial Intelligence,

Digital Health Funding Is Bouncing Back: 3 Things to Know

Digital health startups across the globe raised $5 billion during the first quarter of this year — which is the highest quarterly investment total the space has seen since the second quarter of 2022.

By Katie Adams

Payers, Legal

DOJ Sues MA Insurers, Brokers Over Alleged Kickbacks

The Department of Justice has filed a complaint against Aetna, Elevance Health, Humana, eHealth, GoHealth, and SelectQuote, alleging that the insurers paid illegal kickbacks to brokers to boost enrollment in their Medicare Advantage plans.

By Marissa Plescia

BioPharma, Pharma

FDA Pushes Out Decision for Cytokinetics Heart Drug to Review Proposed Safety Plan

The FDA asked Cytokinetics for the Risk Evaluation and Mitigation Strategy after it had already accepted the application for aficamten, a potential competitor to Bristol Myers Squibbs heart drug Camzyos. Analysts say this development could signal a change in FDA thinking about risk management for the broader drug class.

By Frank Vinluan

MedCity Influencers

AI in Clinical Settings: Balancing Innovation, Patient Care, and Personalized Medicine

AI addresses the disconnect between recommended guidelines and action by increasing engagement with personalized, actionable education and updates at appropriate times,

By Shaji Nair and Ashish Verma

MedCity Influencers

3 Ways Companies Can Make Healthcare More Affordable

As healthcare costs continue to rise, three data-driven strategies can help companies reduce the expense of employee health benefits – without sacrificing quality.

By Marcy Tatsch

Events

Time is Running Out to Join the Healthcare Innovation Conversation at INVEST 2025

MedCity INVEST is a boutique healthcare investor conference scheduled for May 20-21 at the Willis Tower in Chicago. Register today!

By Stephanie Baum

Payers, Consumer / Employer

How Imagine360 Saved this Employer 19% Compared to Traditional Health Plans

An analysis by Axene Health Partners revealed that Imagine360 delivered 19% in annual savings—equating to $7.7 million—compared to traditional health plans for Rollins, a pest control company.

By Marissa Plescia